This week added another 12 companies! Luzhou Laojiao and many other stocks disclosed shareholding repurchase and refinancing plans, a list of related A-shares is provided.

According to incomplete Statistics from the Financial Association, 12 A-share listed companies announced the disclosure of shareholding repurchase and related loan situations this week (attached table); Shaanxi Energy shareholder Yunnan Huishen intends to increase its shareholding in the company by 0.25 billion yuan to -0.5 billion yuan, with a loan not exceeding 0.45 billion yuan.

cls.cnMar 16 09:37

The three major Hong Kong stock indices have collectively surged, with major financial and Consumer stocks leading the way! What has happened? Three Bullish factors are about to arrive.

The heavyweight stocks have finally risen!

Brokerage ChinaMar 14 12:21

Is Baijiu(Chinese Liquor) saved? After the Spring Festival, several Baijiu(Chinese Liquor) Funds rose over 10%. Have the investors who entered at a high point recovered their capital?

① Funds heavily invested in Baijiu are rebounding, with many products increasing over 10% after the holiday; ② Investors who poured into funds focused on Baijiu three years ago are still at a loss; ③ A total of 19 related Baijiu stocks are heavily held by public funds, with the market value of Kweichow Moutai's heavy holdings significantly reduced from its peak.

cls.cnMar 13 09:52

Express News | DeepSeek-R2 will be released on March 17, and there has been no official response yet.

BreakingsMar 11 15:22

Weekend reading | What is the "yardstick" for the growth potential of POP MART, which is small yet resilient?

The controversy in the Capital Markets regarding POP MART lies in the fact that trendy toys are neither a necessity nor frequently purchased, and the market size is extremely limited, which is contrary to the rapid growth sought by venture capitalists. However, trendy toys have become a lucrative business, shining alongside the heavily funded thighs of investment committees in high-end office buildings.

Yuan Chuan Research InstituteMar 9 14:11

Two Sessions Time | National People's Congress Representative, Lu Qingguo from Chenguang Biotech Group: Improve the quality standards of Chinese Patent Medicine, regulate the centralized procurement model for Traditional Chinese Medicine, and optimize the

① Lu Qingguo, Director of Chenguang Biotech Group and a representative of the National People's Congress, focused on several recommendations at this year's Two Sessions, including optimizing the procurement mechanism for Traditional Chinese Medicine, enhancing the quality standards for Chinese Patent Medicine, and standardizing the Traditional Chinese Medicine granule industry; ② In addition to recommendations related to the Traditional Chinese Medicine industry, Lu Qingguo prepared several suggestions on rural social retirement insurance, rural medical insurance, and increasing support for companies sanctioned by the United States.

cls.cnMar 3 10:09